To investigate antihyperglycemic and antihyperlipidemic potential of safrole in rodents by in-vivo and in-vitro study.
In the present investigation anti-diabetic and in-vitro antioxidant potential of safrole were evaluated (100 and 200 mg/kg p.o.) in acute and chronic Streptozotocin-nicotinamide (STZ) induced antihyperglycemic rat model. The oral administration of safrole.....